Sirona Biochem (SRBCF) has a profit margin of 16294.87%, above the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Jul 2024
Trailing 12 months ending Jul 2024
The latest profit margin for SRBCF is 16294.87% as of July 2024. That compares with -2696.95% in the prior-year period — up 704.2% year over year. That is above the Healthcare sector average of 17.63%. Investors often review this figure alongside Sirona Biochem's historical trend and sector peers before judging valuation or financial health.
Over the past year, SRBCF's profit margin moved from -2696.95% to 16294.87% — a 704.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sirona Biochem's valuation or profitability profile.
Against Healthcare companies, SRBCF currently prints 16294.87% for profit margin, while the sector average sits near 17.63%. That is roughly 92334.8% above the sector mean. Large gaps often invite a closer look at Sirona Biochem's growth, margins, and balance sheet.
Profit Margin shows how effectively Sirona Biochem converts resources into returns. At 16294.87%, SRBCF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2696.95% in the prior-year period — up 704.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SRBCF's profit margin (16294.87%), review year-over-year change from -2696.95%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.